Cato T. Laurencin

CIK: 0001444810

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (7.7%)

Position reduction

Option Exercises (M)4 (30.8%)

Derivative conversions

Awards (A)5 (38.5%)

Compensation grants

Other (G, F, J, C, D, …)3 (23.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ALKS

Alkermes plc.

Director

MDXG

MIMEDX GROUP, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

ALKS
Alkermes plc.
May 21, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $36.95$55K
ALKS
Alkermes plc.
May 21, 2026
Exercise(M)
Direct
6.1K shares-
ALKS
Alkermes plc.
May 20, 2026
Award(A)
Restricted Stock Unit Award
Direct
5.4K shares-
ALKS
Alkermes plc.
May 20, 2026
Award(A)
Non Qualified Stock Option (Right to Buy)
Direct
11.5K shares-
MDXG
MIMEDX GROUP, INC.
Jun 18, 2025
Award(A)
Direct
28.6K shares at avg. $6.47$185K
ALKS
Alkermes plc.
May 31, 2025
Tax Payment(F)
Direct
1.9K shares at avg. $30.61$59K
ALKS
Alkermes plc.
May 31, 2025
Exercise(M)
Direct
8K shares-
ALKS
Alkermes plc.
May 21, 2025
Award(A)
Non Qualified Stock Option (Right to Buy)
Direct
13.5K shares-
ALKS
Alkermes plc.
May 21, 2025
Award(A)
Restricted Stock Unit Award
Direct
6.1K shares-
ALKS
Alkermes plc.
Dec 9, 2024
Exercise(M)
Direct
2.7K shares at avg. $22.52$61K
ALKS
Alkermes plc.
Dec 9, 2024
Sale(S)
Direct
2.7K shares at avg. $31.85$86K
ALKS
Alkermes plc.
Dec 8, 2024
Exercise(M)
Direct
4.2K shares-
ALKS
Alkermes plc.
Dec 8, 2024
Tax Payment(F)
Direct
958 shares at avg. $31.46$30K

		Type	Shares	Price		Ownership
May 21, 2026	ALKS Alkermes plc.	Tax Payment(F)	1,475	$36.95	$54,501	Direct
May 21, 2026	ALKS Alkermes plc.	Exercise(M)	6,142	-	$0	Direct
May 20, 2026	ALKS Alkermes plc.	Award(A) Restricted Stock Unit Award	5,409	-	-	Direct
May 20, 2026	ALKS Alkermes plc.	Award(A) Non Qualified Stock Option (Right to Buy)	11,538	-	-	Direct
Jun 18, 2025	MDXG MIMEDX GROUP, INC.	Award(A)	28,609	$6.47	$185,100	Direct
May 31, 2025	ALKS Alkermes plc.	Tax Payment(F)	1,924	$30.61	$58,894	Direct
May 31, 2025	ALKS Alkermes plc.	Exercise(M)	8,013	-	-	Direct
May 21, 2025	ALKS Alkermes plc.	Award(A) Non Qualified Stock Option (Right to Buy)	13,474	-	-	Direct
May 21, 2025	ALKS Alkermes plc.	Award(A) Restricted Stock Unit Award	6,142	-	-	Direct
Dec 9, 2024	ALKS Alkermes plc.	Exercise(M)	2,691	$22.52	$60,601	Direct
Dec 9, 2024	ALKS Alkermes plc.	Sale(S)	2,691	$31.85	$85,708	Direct
Dec 8, 2024	ALKS Alkermes plc.	Exercise(M)	4,163	-	$0	Direct
Dec 8, 2024	ALKS Alkermes plc.	Tax Payment(F)	958	$31.46	$30,139	Direct

1-13 of 13 transactions

About LAURENCIN CATO T

LAURENCIN CATO T (SEC CIK 0001444810) files insider reports with the SEC as Director of Alkermes plc. (ALKS) and Director of MIMEDX GROUP, INC. (MDXG).

Signal8 holds 5 ownership filings by LAURENCIN CATO T, all Form 4s, filed between Dec 9, 2024 and May 22, 2026. Those filings report 13 transactions, from Dec 8, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LAURENCIN CATO T's filings is in DUBLIN.

Recent filings by LAURENCIN CATO T

May 21, 2026: Tax withholding of ALKS shares (Form 4, code F).
May 21, 2026: Option exercise of ALKS shares (Form 4, code M).
May 20, 2026: Grants or awards of ALKS derivative securities (2 lines, Form 4, code A).
Jun 18, 2025: Grant or award of MDXG shares (Form 4, code A).
May 31, 2025: Tax withholding of ALKS shares (Form 4, code F).

Other insiders filing for Alkermes plc. (ALKS)

Gaffin David Joseph, EVP, CLO, Alkermes, Inc.
Reed Joshua, SVP, Chief Financial Officer
Whitaker Anne Clem, Director
Hopkinson Craig C., EVP R&D, Chief Medical Officer
Nichols Christian Todd, SVP, Chief Commercial Officer
Jackson Blair Curtis, President & CEO, Alkermes plc

How to read Form 4 transaction codes